Decisions to get HIV tested and to accept antiretroviral therapies among gay/bisexual men: implications for secondary prevention efforts.

The objective of this study was to report prevalence rates of adherence by HIV-seropositive individuals to medical recommendations for the treatment of HIV infection, a behavioral pattern referred to as AIDS secondary prevention. We report cross-sectional data (n = 2,593) from two household-based and two bar-based samples of gay/bisexual men, gathered in 1992 in Tucson, Arizona, and Portland, Oregon. The main outcome variables were prevalence of HIV antibody testing and adherence to recommended secondary prevention behaviors to prevent onset of AIDS symptoms. Approximately one-third of the gay/bisexual men in these samples do not know their current HIV status. Of the gay/bisexual men who do know that they are HIV-seropositive, approximately three-fourths adhere to each of the secondary prevention recommendations, as appropriate to their stage of disease progression. In a multivariate logistic model, three variables distinguished between HIV-seropositive men who did and did not adhere: perceived antiviral treatment norms (OR = 1.4, CI = 1.1-1.7), perceived efficacy of secondary prevention treatments (OR = 1.4, CI = 1.1-1.7), and quality of the relationship with one's health-care provider (OR = 2.5, CI = 1.6-4.0). These findings indicate that efforts to support AIDS secondary prevention behaviors can occur not only through health education to change the perceptions of at-risk communities about the options available to delay the onset of opportunistic infections among HIV-seropositive individuals but also by enhancing effective doctor/patient communication.

[1]  D. Locker,et al.  Factors affecting gay and bisexual men's decisions and intentions to seek HIV testing. , 1993, American journal of public health.

[2]  T. Coates,et al.  AIDS and sexual behavior reported by gay men in San Francisco. , 1985, American journal of public health.

[3]  J. Rabkin,et al.  Coping strategies and health beliefs of AIDS longterm survivors , 1992 .

[4]  C. Hoff,et al.  Longitudinal predictors of reductions in unprotected anal intercourse among gay men in San Francisco: the AIDS Behavioral Research Project. , 1990, American journal of public health.

[5]  P. Volberding,et al.  Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group. , 1994, The New England journal of medicine.

[6]  J. Catania,et al.  A comparison of younger and older gay men's HIV risk-taking behaviors: the Communication Technologies 1989 Cross-Sectional Survey. , 1992, Journal of acquired immune deficiency syndromes.

[7]  J. Aboulker,et al.  Preliminary analysis of the Concorde trial , 1993, The Lancet.

[8]  S. Shiboski,et al.  Changes in AIDS survival time in two San Francisco cohorts of homosexual men, 1983 to 1993. , 1994, JAMA.

[9]  Anne M Johnson,et al.  Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine , 1994 .

[10]  J. Nielsen,et al.  Comparison of long-term prognosis of patients with AIDS treated and not treated with zidovudine. AIDS in Europe Study Group. , 1994, JAMA.

[11]  V. Raveis,et al.  Factors associated with urban gay men's treatment initiation decisions for HIV infection. , 1992, AIDS education and prevention : official publication of the International Society for AIDS Education.

[12]  M K O'Brien,et al.  Adherence to Medication Regimens: Updating a Complex Medical Issue , 1992, Medical care review.

[13]  J. Levy,et al.  Sexual practices and risk of infection by the human immunodeficiency virus. The San Francisco Men's Health Study. , 1987, JAMA.